Clinical trial finds dendritic cell vaccine safe, induced immune responses in patients with multiple myeloma
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma, according ...
2 hours ago
0
51